NFLD Northfield Laboratories Inc. (MM)

Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the Rodman & Renshaw 10thAnnual Healthcare Conference on Tuesday, November 11, 2008, at 3:15 p.m. ET. Interested investors may access the live webcast of the presentation at www.northfieldlabs.com. A replay of the presentation will be available and will be archived for two weeks. About Northfield Laboratories Northfield Laboratories is a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute. The initial indication we are seeking for our product PolyHeme� is the treatment of life-threatening hemoglobin levels when blood transfusion is indicated but red blood cells may not be available, appropriate or acceptable. PolyHeme� is a solution of chemically modified human hemoglobin that requires no cross-matching and is therefore compatible with all blood types. It has an extended shelf life in excess of 12 months. For further information, visit http://www.northfieldlabs.com